Question 1

Does UBS Group own AKTX stock?

Accepted Answer

No. UBS Group exited its AKTX (Akari Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 32,855 shares worth $9,496.

Question 2

How many shares of AKTX does UBS Group own?

Accepted Answer

None since Q1 2026, when UBS Group exited the position. Its Q4 2025 13F listed 32,855 shares worth $9,496.

Question 3

What is UBS Group's AKTX position worth?

Accepted Answer

UBS Group's AKTX position was worth $9,496 in its Q4 2025 13F, before the exit in Q1 2026.

Question 4

Is UBS Group buying or selling AKTX?

Accepted Answer

In Q1 2026, UBS Group exited its entire AKTX position.

Question 5

When did UBS Group first buy AKTX?

Accepted Answer

UBS Group first reported AKTX in its Q2 2024 13F and listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$5.15	0
2025-Q4	Increased	32,855	+547x	$9,496	0.0%	$11.56	19
2025-Q3	Decreased	60	-97.2%	$61	0.0%	$40.40	0
2025-Q2	New	2,154	—	$2,520	0.0%	$46.80	19
2025-Q1	Exited	0	-100.0%	$0	0.0%	$49.60	0
2024-Q4	New	194	—	$237	0.0%	$48.80	17
2024-Q3	Exited	0	-100.0%	$0	0.0%	$118.00	0